Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02447406
Recruitment Status : Unknown
Verified February 2017 by Seung tae Kim, Samsung Medical Center.
Recruitment status was:  Recruiting
First Posted : May 18, 2015
Last Update Posted : February 16, 2017
Sponsor:
Information provided by (Responsible Party):
Seung tae Kim, Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : January 2019